Effect of Mixed On-line Hemodiafiltration on Circulating Markers of Inflammation and Vascular Dysfunction
1 other identifier
interventional
30
1 country
1
Brief Summary
On line haemodiafiltration (OL-HDF) has been shown to improve intra-dialytic hemodynamics and cardiovascular outcomes. Several potential candidates of these beneficial effects have been explored. The aim of this study was to investigate the impact of mixed OL-HDF (mOL-HDF) on different circulating mediators of vascular dysfunction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Feb 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 3, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 11, 2014
CompletedFirst Submitted
Initial submission to the registry
June 8, 2017
CompletedFirst Posted
Study publicly available on registry
June 28, 2017
CompletedJune 29, 2017
June 1, 2017
7 days
June 8, 2017
June 27, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
RNA content of circulating particles
Quantitative micro-RNA changes in plasmatic exosomes/microvesicles assessed by quantitative real-time PCR
Study start (time 0) and study end (9 months)
Secondary Outcomes (2)
Circulating inflammatory markers
All the study timepoints: time 0 and 3, 6, 9 months
RNA content of circulating particles
All the study timepoints: time 0 and 3, 6, 9 months
Study Arms (2)
Mixed on-line hemodiafiltration
EXPERIMENTALMixed on-line hemodiafiltration (mOL-HDF using FX 1000 CorDiax, Fresenius Medical Care, Bad Homburg, Germany), three sessions per week, four hours per session
High flux bicarbonate dialysis
ACTIVE COMPARATORStandard high flux bicarbonate dialysis with polysulfone membrane, three sessions per week, four hours per session
Interventions
This is a mixed hemodepurative technique exploiting diffusion and convection through a semi-permeable membrane. Dialysis solution is not only interfacing with blood through the membrane (as in bicarbonate hemodialysis) but it is also mixed with it with a pre- and a post- filter dilution. The same amount of fluid added to the bloodstream is then removed within the filter through an appropriate negative pressure in the dialysis solution compartment and thanks a high permeability membrane. Patients will be treated three sessions per week, four hours per session
Standard high flux bicarbonate dialysis with polysulfone membrane, three sessions per week, four hours per session
Eligibility Criteria
You may qualify if:
- hemodialytic treatment from at least 6 months (3 times for week), blood flow rate during dialysis session (Qb) ≥250 ml/min using arterovenous fistula (AVF) or permanent central venous catheter (CVC), blood creatinine clearance \<5 ml/min, urine output \<500 ml/die.
You may not qualify if:
- neoplastic diseases, autoimmune diseases, solid organ or bone marrow transplantation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Città della Salute e Della Scienza di Torino - Presidi CTO e Molinette
Torino, To, 10126, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator - Associate Professor of Nephrology
Study Record Dates
First Submitted
June 8, 2017
First Posted
June 28, 2017
Study Start
February 3, 2014
Primary Completion
February 10, 2014
Study Completion
November 11, 2014
Last Updated
June 29, 2017
Record last verified: 2017-06
Data Sharing
- IPD Sharing
- Will share
At the time of registration the study was already completed. IPD data will be available upon request till the study publication, then data will be enclosed within the publication as supplementary material.